2m 2m 2m 2m 2m 2m 2m
BEAM THERAPEUTIC (BEAM)
NASDAQ
$25.54+$0.39 (+1.57%)
Price as of Nov 11, 2026 7:36 PM EST- $2.6BMarket Cap
- 11.88%1-Year Change
- BiotechnologyIndustry
BEAM THERAPEUTIC (BEAM)
$25.54+$0.39 (+1.57%)
BEAM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $25.15 | ||
Change | -$1.87 (-6.92%) | ||
Open | $26.45 | ||
High | $27.00 | ||
Low | $23.60 | ||
Previous Close | $27.02 | ||
Volume | 3,115,601 | ||
30-Day Average Volume | 1,881,383 | ||
1-Week Change | -4.48% | ||
1-Month Change | -2.14% | ||
1-Year Change | 11.88% | ||
3-Year Change | 13.49% | ||
5-Year Change | -72.39% | ||
Fundamentals | |||
Shares Outstanding | 103.5M | ||
Total Assets | $1.3B | ||
Market Cap | $2.6B | ||
Enterprise Value | $2.5B | ||
Period: QTR TTM FY | |||
Revenue | $307,000.00 | ||
Net Income | -$134.4M | ||
Free Cash Flow | -$112.0M | ||
EBIT | -$131.7M | ||
EBITDA | -$126.2M | ||
Net Working Capital | $985.3M | ||
EPS | -$1.28 | ||
Enterprise Value/EBITDA | -20 | ||
Enterprise Value/Revenue | 8,111 | ||
P/B | 3 | ||
P/E | -20 | ||
PEG | 2 | ||
Price/Free Cash Flow | -23 | ||
Price/Operating Cash Flow | -24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 02/04/2014 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue